CN109293758B - 抗黄萎病相关蛋白GbVIP1及其编码基因与应用 - Google Patents
抗黄萎病相关蛋白GbVIP1及其编码基因与应用 Download PDFInfo
- Publication number
- CN109293758B CN109293758B CN201811277409.2A CN201811277409A CN109293758B CN 109293758 B CN109293758 B CN 109293758B CN 201811277409 A CN201811277409 A CN 201811277409A CN 109293758 B CN109293758 B CN 109293758B
- Authority
- CN
- China
- Prior art keywords
- gbvip1
- verticillium wilt
- gene
- cotton
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 85
- 241000082085 Verticillium <Phyllachorales> Species 0.000 title claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 33
- 229920000742 Cotton Polymers 0.000 claims abstract description 43
- 235000009429 Gossypium barbadense Nutrition 0.000 claims abstract description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 7
- 244000299507 Gossypium hirsutum Species 0.000 claims description 6
- 238000010353 genetic engineering Methods 0.000 claims description 4
- 235000018322 upland cotton Nutrition 0.000 claims description 4
- 241000219146 Gossypium Species 0.000 abstract description 42
- 240000000047 Gossypium barbadense Species 0.000 abstract description 13
- 230000030279 gene silencing Effects 0.000 abstract description 11
- 238000009395 breeding Methods 0.000 abstract description 9
- 230000001488 breeding effect Effects 0.000 abstract description 8
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 abstract description 4
- 108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 241001123668 Verticillium dahliae Species 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 description 43
- 239000013598 vector Substances 0.000 description 29
- 201000010099 disease Diseases 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- 101000953492 Homo sapiens Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Proteins 0.000 description 17
- 241000589158 Agrobacterium Species 0.000 description 16
- 102100037739 Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Human genes 0.000 description 15
- 238000011081 inoculation Methods 0.000 description 15
- 239000013604 expression vector Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 241000208125 Nicotiana Species 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000003259 recombinant expression Methods 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 8
- 230000009261 transgenic effect Effects 0.000 description 8
- 238000012258 culturing Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000028604 virus induced gene silencing Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000043136 MAP kinase family Human genes 0.000 description 3
- 108091054455 MAP kinase family Proteins 0.000 description 3
- 241000207746 Nicotiana benthamiana Species 0.000 description 3
- 101150083215 VIP1 gene Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 241000364051 Pima Species 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000002856 computational phylogenetic analysis Methods 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- WOJJIRYPFAZEPF-YFKPBYRVSA-N 2-[[(2s)-2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]propanoyl]amino]acetate Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)CN WOJJIRYPFAZEPF-YFKPBYRVSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- BLGHHPHXVJWCNK-GUBZILKMSA-N Ala-Gln-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BLGHHPHXVJWCNK-GUBZILKMSA-N 0.000 description 1
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 1
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 1
- 108010076441 Ala-His-His Proteins 0.000 description 1
- ATAKEVCGTRZKLI-UWJYBYFXSA-N Ala-His-His Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 ATAKEVCGTRZKLI-UWJYBYFXSA-N 0.000 description 1
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 1
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 1
- PEEYDECOOVQKRZ-DLOVCJGASA-N Ala-Ser-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PEEYDECOOVQKRZ-DLOVCJGASA-N 0.000 description 1
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 101000953539 Arabidopsis thaliana Transcription factor VIP1 Proteins 0.000 description 1
- YFWTXMRJJDNTLM-LSJOCFKGSA-N Arg-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFWTXMRJJDNTLM-LSJOCFKGSA-N 0.000 description 1
- RWCLSUOSKWTXLA-FXQIFTODSA-N Arg-Asp-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RWCLSUOSKWTXLA-FXQIFTODSA-N 0.000 description 1
- YSUVMPICYVWRBX-VEVYYDQMSA-N Arg-Asp-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YSUVMPICYVWRBX-VEVYYDQMSA-N 0.000 description 1
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 1
- JOTRDIXZHNQYGP-DCAQKATOSA-N Arg-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N JOTRDIXZHNQYGP-DCAQKATOSA-N 0.000 description 1
- IZSMEUDYADKZTJ-KJEVXHAQSA-N Arg-Tyr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IZSMEUDYADKZTJ-KJEVXHAQSA-N 0.000 description 1
- CIBWFJFMOBIFTE-CIUDSAMLSA-N Asn-Arg-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N CIBWFJFMOBIFTE-CIUDSAMLSA-N 0.000 description 1
- JREOBWLIZLXRIS-GUBZILKMSA-N Asn-Glu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JREOBWLIZLXRIS-GUBZILKMSA-N 0.000 description 1
- GJFYPBDMUGGLFR-NKWVEPMBSA-N Asn-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC(=O)N)N)C(=O)O GJFYPBDMUGGLFR-NKWVEPMBSA-N 0.000 description 1
- SPKRHJOVRVDJGG-CIUDSAMLSA-N Asp-Gln-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N SPKRHJOVRVDJGG-CIUDSAMLSA-N 0.000 description 1
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 1
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- KMHZPJNVPCAUMN-UHFFFAOYSA-N Erbon Chemical compound CC(Cl)(Cl)C(=O)OCCOC1=CC(Cl)=C(Cl)C=C1Cl KMHZPJNVPCAUMN-UHFFFAOYSA-N 0.000 description 1
- PKVWNYGXMNWJSI-CIUDSAMLSA-N Gln-Gln-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKVWNYGXMNWJSI-CIUDSAMLSA-N 0.000 description 1
- KVXVVDFOZNYYKZ-DCAQKATOSA-N Gln-Gln-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KVXVVDFOZNYYKZ-DCAQKATOSA-N 0.000 description 1
- LVRKAFPPFJRIOF-GARJFASQSA-N Gln-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N LVRKAFPPFJRIOF-GARJFASQSA-N 0.000 description 1
- NPMFDZGLKBNFOO-SRVKXCTJSA-N Gln-Pro-His Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NPMFDZGLKBNFOO-SRVKXCTJSA-N 0.000 description 1
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 1
- HNAUFGBKJLTWQE-IFFSRLJSSA-N Gln-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N)O HNAUFGBKJLTWQE-IFFSRLJSSA-N 0.000 description 1
- OJGLIOXAKGFFDW-SRVKXCTJSA-N Glu-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N OJGLIOXAKGFFDW-SRVKXCTJSA-N 0.000 description 1
- XHWLNISLUFEWNS-CIUDSAMLSA-N Glu-Gln-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XHWLNISLUFEWNS-CIUDSAMLSA-N 0.000 description 1
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 1
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 1
- XRTDOIOIBMAXCT-NKWVEPMBSA-N Gly-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)CN)C(=O)O XRTDOIOIBMAXCT-NKWVEPMBSA-N 0.000 description 1
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 1
- QPDUVFSVVAOUHE-XVKPBYJWSA-N Gly-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(O)=O QPDUVFSVVAOUHE-XVKPBYJWSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- IDNNYVGVSZMQTK-IHRRRGAJSA-N His-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N IDNNYVGVSZMQTK-IHRRRGAJSA-N 0.000 description 1
- ZNNNYCXPCKACHX-DCAQKATOSA-N His-Gln-Gln Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZNNNYCXPCKACHX-DCAQKATOSA-N 0.000 description 1
- OZBDSFBWIDPVDA-BZSNNMDCSA-N His-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC3=CN=CN3)N OZBDSFBWIDPVDA-BZSNNMDCSA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- NULSANWBUWLTKN-NAKRPEOUSA-N Ile-Arg-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N NULSANWBUWLTKN-NAKRPEOUSA-N 0.000 description 1
- ZDNORQNHCJUVOV-KBIXCLLPSA-N Ile-Gln-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O ZDNORQNHCJUVOV-KBIXCLLPSA-N 0.000 description 1
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 1
- 241001237160 Kallima inachus Species 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- DBVWMYGBVFCRBE-CIUDSAMLSA-N Leu-Asn-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DBVWMYGBVFCRBE-CIUDSAMLSA-N 0.000 description 1
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- CPONGMJGVIAWEH-DCAQKATOSA-N Leu-Met-Ala Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O CPONGMJGVIAWEH-DCAQKATOSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 1
- SVBJIZVVYJYGLA-DCAQKATOSA-N Leu-Ser-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O SVBJIZVVYJYGLA-DCAQKATOSA-N 0.000 description 1
- FGZVGOAAROXFAB-IXOXFDKPSA-N Leu-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N)O FGZVGOAAROXFAB-IXOXFDKPSA-N 0.000 description 1
- GAOJCVKPIGHTGO-UWVGGRQHSA-N Lys-Arg-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O GAOJCVKPIGHTGO-UWVGGRQHSA-N 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- FJVJLMZUIGMFFU-BQBZGAKWSA-N Met-Asp-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FJVJLMZUIGMFFU-BQBZGAKWSA-N 0.000 description 1
- DJDFBVNNDAUPRW-GUBZILKMSA-N Met-Glu-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O DJDFBVNNDAUPRW-GUBZILKMSA-N 0.000 description 1
- CHQWUYSNAOABIP-ZPFDUUQYSA-N Met-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N CHQWUYSNAOABIP-ZPFDUUQYSA-N 0.000 description 1
- ZIIMORLEZLVRIP-SRVKXCTJSA-N Met-Leu-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZIIMORLEZLVRIP-SRVKXCTJSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- HXSUFWQYLPKEHF-IHRRRGAJSA-N Phe-Asn-Arg Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HXSUFWQYLPKEHF-IHRRRGAJSA-N 0.000 description 1
- MRNRMSDVVSKPGM-AVGNSLFASA-N Phe-Asn-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRNRMSDVVSKPGM-AVGNSLFASA-N 0.000 description 1
- ZENDEDYRYVHBEG-SRVKXCTJSA-N Phe-Asp-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZENDEDYRYVHBEG-SRVKXCTJSA-N 0.000 description 1
- CSYVXYQDIVCQNU-QWRGUYRKSA-N Phe-Asp-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O CSYVXYQDIVCQNU-QWRGUYRKSA-N 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- OAOLATANIHTNCZ-IHRRRGAJSA-N Phe-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N OAOLATANIHTNCZ-IHRRRGAJSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- QBFONMUYNSNKIX-AVGNSLFASA-N Pro-Arg-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QBFONMUYNSNKIX-AVGNSLFASA-N 0.000 description 1
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 1
- ZCXQTRXYZOSGJR-FXQIFTODSA-N Pro-Asp-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZCXQTRXYZOSGJR-FXQIFTODSA-N 0.000 description 1
- KTFZQPLSPLWLKN-KKUMJFAQSA-N Pro-Gln-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KTFZQPLSPLWLKN-KKUMJFAQSA-N 0.000 description 1
- JLMZKEQFMVORMA-SRVKXCTJSA-N Pro-Pro-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 JLMZKEQFMVORMA-SRVKXCTJSA-N 0.000 description 1
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 1
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- VIBXMCZWVUOZLA-OLHMAJIHSA-N Thr-Asn-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VIBXMCZWVUOZLA-OLHMAJIHSA-N 0.000 description 1
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 1
- MSIYNSBKKVMGFO-BHNWBGBOSA-N Thr-Gly-Pro Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N)O MSIYNSBKKVMGFO-BHNWBGBOSA-N 0.000 description 1
- IMDMLDSVUSMAEJ-HJGDQZAQSA-N Thr-Leu-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IMDMLDSVUSMAEJ-HJGDQZAQSA-N 0.000 description 1
- UJQVSMNQMQHVRY-KZVJFYERSA-N Thr-Met-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O UJQVSMNQMQHVRY-KZVJFYERSA-N 0.000 description 1
- WRQLCVIALDUQEQ-UNQGMJICSA-N Thr-Phe-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WRQLCVIALDUQEQ-UNQGMJICSA-N 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 1
- NYTKXWLZSNRILS-IFFSRLJSSA-N Val-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N)O NYTKXWLZSNRILS-IFFSRLJSSA-N 0.000 description 1
- OQWNEUXPKHIEJO-NRPADANISA-N Val-Glu-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N OQWNEUXPKHIEJO-NRPADANISA-N 0.000 description 1
- YMTOEGGOCHVGEH-IHRRRGAJSA-N Val-Lys-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O YMTOEGGOCHVGEH-IHRRRGAJSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 108010072637 phenylalanyl-arginyl-phenylalanine Proteins 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012883 rooting culture medium Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种抗黄萎病相关蛋白GbVIP1及其编码基因与应用,其氨基酸序列如SEQ ID NO:1所示。本发明蛋白GbVIP1来自抗黄萎病海岛棉品种海7124,属于bZIP转录因子家族的I亚家族,具有保守的bZIP结构域。本发明研究发现黄萎病菌侵染条件下GbVIP1基因上调表达,沉默GbVIP1基因降低了海岛棉对黄萎病菌的抵抗能力,所以GbVIP1蛋白对棉花抗黄萎病育种具有重要的意义。
Description
技术领域
本发明涉及生物技术领域,特别是涉及一种抗黄萎病相关蛋白GbVIP1及其编码基因与应用。
背景技术
黄萎病是我国棉花生产上危害最为严重的病害,我国西北内陆、黄河流域和长江流域三大棉区每年都不同程度的受到黄萎病的危害,年发生面积约300万hm2,年经济损失高达12亿元(朱荷琴,李志芳,冯自力等.我国棉花黄萎病研究十年回顾及展望,棉花学报,2017,29(增刊):37-50)。通过长期对棉花黄萎病的防治实践表明,选育和种植抗病品种才是防治棉花黄萎病最有效、最经济的措施。但我国陆地棉对黄萎病菌免疫及高抗的种质资源缺乏,而且抗黄萎病海岛棉无法大面积推广,加之传统育种周期长、效率低,导致传统育种方法选育抗黄萎病品种进展缓慢,所以很多研究人员运用现代基因工程技术,以期找到棉花抗黄萎病的关键蛋白,并利用抗病蛋白结合分子育种手段选育抗黄萎病棉花品种。
VirE2互作蛋白1(VIP1,VirE2interacting proteins 1)是植物碱性亮氨酸拉链(bZIP,Basic leucine zipper)转录因子,具有保守的bZIP结构域,属于bZIP转录因子家族的I亚家族(Jakoby M,Weisshaar B,Droge-Laser W,Vicente-Carbajosa J,Tiedemann J,Kroj T,Parcy F.bZIP transcription factors in Arabidopsis.Trends Plants Sci,2002,7(3):106-111)。VIP1蛋白通过与基因组中的VIP1应答原件(VRE,VIP1responseelement)结合,可激活许多抗逆相关基因的转录,引起植物的抗性反应(Lacroix B,Citovsky V.Characterization of VIP1activity as a transcriptional regulator invitro and in planta.Sci Rep,2013,3(8):2440)。当植物受到病原菌侵害时,VIP1蛋白可参与MAPK(Mitogen-activated protein kinases)途径,作为MAPK蛋白的底物被磷酸化,磷酸化的VIP1蛋白可定位于细胞核,激活病程相关基因PR1(Pathogenesis-regulatedprotein)的表达,提高植物对病原菌的抗性(Zaltsman A,Krichevsky A,Kozlovsky S V,Yasmin F,Citovsky V,Plant defense pathways subverted by Agrobacterium forgenetic transformation,Plant Signaling and Behavior,5:10,1245-1248.)。
发明内容
本发明的目的是提供一种抗黄萎病相关蛋白GbVIP1及其编码基因与应用。
本发明的技术方案具体如下:
一种抗黄萎病相关蛋白GbVIP1,其氨基酸序列如SEQ ID NO:1所示。
本发明所述的蛋白GbVIP1在棉花抗黄萎病中的应用。
本发明所述的蛋白GbVIP1来源于抗黄萎病海岛棉品种海7124。
本发明所述的蛋白GbVIP1通过基因工程手段培育抗黄萎病陆地棉品种的应用。
一种GbVIP1基因,其核苷酸序列为下列所述之一:
(1)编码如SEQ ID NO:1所示蛋白质的多核苷酸序列;
(2)与上述多核苷酸序列根据碱基互补配对原则互补的多核苷酸序列。
本发明所述的GbVIP1基因,其多核苷酸序列如SEQ ID NO:2所示。
一种重组载体,含有上述的GbVIP1基因。
本发明所述的重组载体为在植物表达载体pBI121的酶切位点BamHI和SacI之间插入GbVIP1基因的重组载体。
一种遗传工程的宿主细胞,含有上述的重组载体。
本发明所述遗传工程的宿主细胞为上述重组载体的大肠杆菌或农杆菌。
本发明的GbVIP1蛋白来自抗黄萎病海岛棉品种海7124,研究发现黄萎病菌侵染条件下GbVIP1基因上调表达,沉默GbVIP1基因降低了海岛棉对黄萎病菌的抵抗能力,所以GbVIP1蛋白对棉花抗黄萎病育种具有重要的意义。
GbVIP1蛋白由337个氨基酸残基组成,其氨基酸序列如SEQ ID NO:1所示,GbVIP1蛋白理论分子量为37.5kDa,理论等电点为7.89,包含保守的bZIP结构域,bZIP结构域中亮氨酸残基位置保守性高,每隔6个氨基酸残基就存在一个亮氨酸。本发明对不同物种的VIP1蛋白进行进化树分析发现来自不同棉花品种的VIP1基因聚在一起。同时,对来自不同物种的VIP1蛋白进行结构域进行分析,发现来自不同物种的VIP1蛋白都包含bZIP结构域。
本发明对VIP1基因在棉花中的组织表达特异性进行分析,发现GbVIP1在棉花根、茎、叶组织中都有表达,其中,在根中的表达量最高。对VIP1基因在棉花接种黄萎病菌后的表达模式进行分析发现在棉花接种黄萎病菌后GbVIP1基因上调表达,在接菌后6h表达量最高,为对照的3.73倍。
本发明利用VIGS技术沉默棉花中的GbVIP1基因,结果表明,GbVIP1基因沉默植株的叶片变黄萎蔫,叶脉呈现黄色网状,株形微显矮化。沉默植株比对照植株的抗黄萎病能力显著下降。接菌后25天调查病指,沉默植株的黄萎病病指为22.5,对照植株的病指为20.83,接菌后35天沉默植株的黄萎病病指为30.54,对照植株的病指为23.45。接菌后35天对棉花植株进行剖杆观察,发现沉默植株的茎秆的木质化程度减弱,维管束导管部发黄褐化。对黄萎病侵染后的棉花叶片进行台盼蓝染色发现沉默植株的叶片死亡细胞的比例更高。所以,GbVIP1基因与棉花抗黄萎病能力正相关,可应用于棉花抗黄萎病育种研究中。
本发明获得了包含上述基因的重组表达载体,将获得的GbVIP1基因构建到表达载体pBI121中,以35S启动子启动基因的表达,NOS终止子终止,以卡那霉素基因作为筛选标记。将上述重组表达载体转入大肠杆菌和农杆菌中,获得了包含上述基因的重组细胞。将包含上述重组表达载体的农杆菌转入烟草中,获得了包含重组表达载体的转基因烟草,包含上述基因的重组表达载体、重组细胞和转基因烟草可为进一步利用该基因奠定基础。
下面结合附图说明和具体实施例对本发明所述的棉花抗黄萎病相关蛋白GbVIP1及其编码基因与应用作进一步说明。
附图说明
图1为克隆海岛棉GbVIP1基因的PCR产物电泳图谱,左侧泳道为2000bpDNA分子量标准,右侧泳道为扩增产物;
图2为黄萎病抗性和敏感品种中VIP1蛋白的序列差异图,海岛棉品种海7124和Pima为抗性品种,陆地棉品种TM-1为敏感性品种;
图3为GbVIP1基因在棉花不同组织中的表达情况,误差线表示标准误差;
图4为GbVIP1蛋白bZIP保守结构域分析,箭头所指为亮氨酸;
图5来自不同物种的VIP1蛋白的进化树分析;
图6来自不同物种的VIP1蛋白的bZIP结构域分析;
图7为包含GbVIP1基因的重组表达载体图;
图8为转基因烟草检测的图片,泳道1为2000bpDNA分子量标准,泳道2为阴性对照,泳道3为阳性对照,泳道4-6为转基因阳性烟草植株;
图9为GbVIP1基因在棉花接种黄萎病菌后的表达情况,误差线表示标准误差,显著性分析***表示P<0.001;
图10为沉默载体pYL156-GbVIP1图;
图11为利用VIGS在海岛棉中沉默GbVIP1基因的照片,沉默GbVIP1基因后显著降低了海岛棉对黄萎病的抗性,pYL156:PDS为阳性对照,pYL156:00为阴性对照;
图12为剖杆观察照片;
图13为台盼蓝染色结果照片。
具体实施方式
实施例1GbVIP1基因的克隆、序列和表达分析
种植海岛棉品种海7124,在幼苗期取棉花叶片,用液氮把棉花叶片研磨成粉末,利用EASYspin Plus植物RNA快速提取试剂盒(艾德莱)提取棉花叶片总RNA,利用反转录试剂盒(TakaRa)合成cDNA。
以合成的cDNA为模板,扩增GbVIP1,所用引物序列为F:5’TACGCCGCCGCTTCTTCCGCCTACA3’;R:5’CTTACCAAGCATTTCCTTCCAACAT3’(如SEQ ID NO:3-4所示)。
利用高保真Taq酶KOD-Plus-Neo(TOYOBO)扩增GbVIP1,20ul反应体系如下,10×PCR buffer for KOD-Plus-Neo,0.2mM dNTPs,1.5mM MgSO4,0.3uM forward primer and0.3uM reverse primer,0.4U KOD-Plus-Neo,200mM cDNA,扩增程序为94℃4min,98℃10s,60℃1min,68℃1min;34个循环,68℃5min,取扩增产物用于琼脂糖凝胶电泳,如图1所示,扩增出1000bp左右的片段。将条带切出,利用琼脂糖凝胶回收试剂盒(天根)回收。将回收产物连接到pLB vector测序载体(天根)中,将重组载体GbVIP1-pLB利用热激法转入大肠杆菌感受态中,获得含有重组载体的大肠杆菌,并测序,最终获得GbVIP1基因的序列信息。
利用同样的方法和引物,从抗性品种海岛棉Pima和敏感品种陆地棉TM-1中扩增了VIP1基因,发现抗感品种VIP1蛋白序列存在一些碱基差异。(图2)选取幼苗期根、茎、叶组织,利用real-time PCR对GbVIP1基因进行组织表达特异性分析。取材后利用上述提取RNA和反转录的方法获得不同组织的cDNA,利用荧光定量试剂SYBR Primix Ex Taq II(TliRNaseH Plus)(TaKaRa)进行real-time PCR。所用的引物序列如下:F:5’CCAATCCCAGTCTGCCACCT R:5’TCAACCCGAGTCCATCAAAGA(如SEQ ID NO:5-6所示)。反应体系如下:10ul2×SYBR Premix Ex Taq II,2ul cDNA template,0.8ul PCR forward primer(10uM),0.8ul PCR reverse primer(10uM),0.4ul ROX and 6ul灭菌水。反应程序:95℃30s,40个循环、95℃5s,60℃34s。利用2-ΔΔCt方法对得到的结果进行处理。结果发现GbVIP1在根、茎、叶组织中都有表达,在根中的表达量最高(图3)。
对GbVIP1蛋白的保守结构域进行分析发现GbVIP1蛋白的bZIP结构域中亮氨酸残基位置保守性高,每隔6个氨基酸残基就存在一个亮氨酸,如图4所示。从NCBI中下载了拟南芥、水稻、烟草等其他物种的VIP1蛋白的氨基酸序列,利用MEGA软件对来自不同物种的VIP1蛋白进行进化树分析发现来自不同棉花品种的VIP1基因具有较高的亲缘关系,聚在一起,如图5所示。同时,对来自不同物种的VIP1蛋白进行结构域进行分析,发现来自不同物种的VIP1蛋白都包含bZIP结构域,如图6所示。
实施例2GbVIP1基因的表达载体、重组表达细胞和转基因烟草的获得
将GbVIP1基因构建到表达载体pBI121中获得重组表达载体,以35S启动子启动基因的表达,以NOS终止子终止基因的表达,以卡纳霉素基因作为筛选标记,具体方法如下,利用实施例1中所得重组载体GbVIP1-pLB为模板,以引物F:acgggggactctagaggatccTACGCCGCCGCTTCTTCC,R:cgatcggggaaattcgagctcCTTACCAAGCATTTCCTTCCAAC(如SEQ ID NO:7-8所示)进行扩增,获得GbVIP1基因序列的PCR产物,利用限制性内切酶SacI和BamHI对pBI121载体进行酶切,得到带酶切位点的线性化质粒,利用同源重组试剂盒(ClonExpress II OneStep Cloning Kit,诺唯赞)将PCR产物构建到沉过表达载体pBI121中,获得了表达载体pBI121-GbVIP1(图7)。
将重组载体pBI121-GbVIP1利用热激法转入大肠杆菌感受态中,获得含有重组载体的大肠杆菌,并测序,最终获得重组表达细胞。
将重组载体pBI121-GbVIP1转入农杆菌细胞GV3101中,转化方法如下:在无菌条件下取50ul农杆菌感受态细胞,加入质粒DNA(pBI121-GbVIP1)1ug,轻轻混匀后,放置冰上30min,之后放于液氮中5min,28度热激5min,加入无抗生素的YEP培养液体培养基,于28度,200r/min震荡培养2h,涂布卡那霉素抗性平板,28度静置培养36h后挑菌测序鉴定。利用农杆菌介导的遗传转化方法将重组载体pBI121-GbVIP1转入烟草中获得转棉花GbVIP1基因的烟草。具体操作如下:
(1)将本氏烟草种子在0.1%的次氯酸钠溶液中灭菌,再用灭菌水冲洗3次,点播于MS培养基中。待种子发芽后在无菌条件下移栽至培养瓶继续培养。
(2)选择叶面平展的本氏烟草叶片,剪成5.0mm×5.0mm大小方块,平铺于MS基本培养基(含MS维生素)+1.0mg L-16-BA+0.2mg L-1IAA的培养基上25℃、光照条件下预培养3d。
(3)侵染前,将含有重组载体pBI121-TaVIP1的农杆菌活化,待农杆菌菌液OD600=0.5时,离心收集菌液,倒掉上清,用MS重悬液(pH 6.0)重悬。
(4)将预培养的本氏烟草叶盘转至农杆菌菌液中侵染20min,取出后用无菌滤纸吸干叶片表面菌液,转移至MS基本培养基+1.0mg L-16-BA+0.2mg L-1IAA的培养皿中,25℃黑暗条件下共培养2d。
(5)将共培养后的叶盘转至筛选培养基(MS基本培养基+1.0mg L-16-BA+0.2mg L- 1IAA+Cb(羧苄青霉素)400mg L-1+Cef(头孢青霉素)100mg L-1+Kan 100mg L-1),25℃、光照条件下培养,每隔3周更换一次培养基
(6)待烟草叶盘周边不定芽长至0.5cm时将不定芽转入生根培养基(1/2MS基本培养基+Cb400mg L-1+Cef100mg L-1+Kan 100mg L-1)进一步筛选、培养。
将高度为2-3cm的再生芽从愈伤组织上分割出来,转移到三角瓶中培养,获得抗性再生植株,利用卡那霉素筛选标记基因对T0代转基因烟草进行PCR检测,所用引物F:5’TACGCCGCCGCTTCTTCCGCCTACA3’R:5’CTTACCAAGCATTTCCTTCCAACAT3’(如SEQ ID NO:9-10所示),能够扩增出1014bpPCR产物的植株即为转海岛棉GbVIP1基因的烟草植株(图8)。该转基因植株对后续GbVIP1蛋白在抗黄萎病育种中的应用奠定了基础
实施例3GbVIP1的功能分析
(1)GbVIP1基因在棉花接种黄萎病菌后的表达模式分析
利用水培法种植棉花,在二叶一心期利用孢子浓度为1*107的棉花黄萎病菌Vd853使用蘸根法侵染棉花幼苗的根部,然后分别取了接菌后0h,6h,12h,24h棉花幼苗的根组织,利用实施例1中所述方法提取了RNA并反转录成cDNA,利用real-time PCR研究了GbVIP1基因在棉花接种黄萎病菌后的表达情况,所用引物和反应体系见实施例1。结果发现在接菌后GbVIP1基因的表达量上调,在接菌后6h,GbVIP1基因的表达量最高,为对照的3.73倍(图9)。由此可推断GbVIP1基因与棉花抗黄萎病能力相关。
(2)利用病毒诱导的基因沉默(VIGS:Virus induced gene silencing)技术在海岛棉中沉默GbVIP1基因
从GbVIP1基因的cDNA序列中选取了272bp保守序列反向构建到沉默载体pYL156中,获得沉默载体pYL156-GbVIP1(图10),具体操作如下,首先,根据实施例1中所得的海岛棉叶片的cDNA作为模板,以引物F ggcctcgagacgcgtgagctcGCCGTTGATGGTGTTAAGAAAAC,R:agaaggcctccatggggatccATAGCCTGTAGCCGTAGTTTCAGTT(如SEQ ID NO:11-12所示)进行扩增,获得了272bp保守序列的PCR产物。利用限制性内切酶SacI和BamHI对pYL156载体进行酶切,得到带酶切位点的线性化质粒,利用同源重组试剂盒(ClonExpress II One StepCloning Kit,诺唯赞)将PCR产物构建到沉默载体pYL156中,获得了沉默载体pYL156-GbVIP1。并将沉默载体转入农杆菌细胞GV3101中,转化方法如实施实例2中所示。将棉花种子用无菌水浸泡24h,露白后种到混好的营养土中(基质:蛭石=1:1),待幼苗子叶完全平展时进行VIGS实验,接种前将携带pYL156-GbVIP1载体的农杆菌、携带对照载体pYL156-GhPDS的农杆菌及携带pYL156空载体和pYL192载体的农杆菌活化,待农杆菌菌液OD600=1.5时,离心收集菌液,利用重悬液(10Mm MgCl2,10mM MES,150uM乙酰丁香酮)将农杆菌重悬,然后携带pYL192载体的农杆菌分别与携带pYL156-GbVIP1,pYL156,pYL156-GhPDS载体的农杆菌1:1混合均匀,静置4h后使用。用1ml的注射器针头在棉花幼苗子叶背面扎1个小孔,然后将菌液注射入棉花子叶中,将注射后的棉花幼苗用褐色塑料布遮盖,避光培养24h,然后光照培养,待对照植株出现白化表型时接种黄萎病菌,接菌后25天和35天调查病情并计算病指,病情调查采用五级划分标准划分田间黄萎病病株级别:0级:无病植株;1级:25%以下叶片发病的植株;2级:25%-50%叶片发病的植株;3级:50%-75%叶片发病的植株;4级:75%以上叶片发病的植株。病情指数计算公式为:
结果发现GbVIP1基因沉默植株的叶片变黄萎蔫,叶脉呈现黄色网状,株形微显矮化。沉默植株比对照植株的抗黄萎病能力显著下降(图11)。接菌后25天调查病指,沉默植株的黄萎病病指为22.5,对照植株的病指为20.83,接菌后35天沉默植株的黄萎病病指为30.54,对照植株的病指为23.45。
用刀片把沉默植株和对照植株的茎秆剖开,在显微镜下观察维管束部位的表型(图12),对黄萎病侵染后的棉花叶片进行台盼蓝染色观察沉默和对照植株的叶片的死亡细胞比例,取沉默和对照植株相同部位的叶片,浸泡在台盼蓝染液(2.5g台盼蓝,25%乳酸,23%水溶苯酚,25%甘油)中,沸水浴染色2min,自然冷却后室温染色过夜,然后置于1.25g/ml水合氯醛溶液脱色3d,每天更换一次脱色液。在体式显微镜下观察细胞死亡情况(图13)。剖杆观察发现沉默植株的茎秆的木质化程度减弱,维管束导管部发黄褐化。台盼蓝染色试验发现沉默植株的叶片死亡细胞的比例更高。所以,GbVIP1基因与棉花抗黄萎病能力正相关,可应用于棉花抗黄萎病育种研究中。
以上所述的实施例仅仅是对本发明的优选实施方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案作出的各种变形和改进,均应落入本发明权利要求书确定的保护范围内。
序列表
<110> 中国农业科学院棉花研究所
<120> 抗黄萎病相关蛋白GbVIP1及其编码基因与应用
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 337
<212> PRT
<213> GbVIP1氨基酸序列(GbVIP1)
<400> 1
Met Glu Gln Lys Leu Arg Met Glu Ile Asp Gln Met Pro Pro Arg Gly
1 5 10 15
Ala His His Arg Arg Ala His Ser Asp Thr Thr Phe Arg Phe Asp Asp
20 25 30
Leu Leu Leu Phe Asp Pro Ser Asp Leu Asp Leu Ser Cys Leu Asp Leu
35 40 45
Pro Asp Ser Ser Ser Asn Pro Ser Leu Pro Pro Val Ala Pro Val Pro
50 55 60
Ala Glu Ser Ser Asp Asp Ser Ser Cys Asn Gly Pro Pro Arg Ser Thr
65 70 75 80
Leu Asn Asn Pro Arg His Ile Arg Ser Leu Ser Val Asp Ser Asp Phe
85 90 95
Phe Asp Gly Leu Gly Leu Thr Gly Pro Ala Ile Ser Gly Gly Ala Gly
100 105 110
Asp Glu Lys Phe Gly Gly Lys Arg Gly Ala Gly Glu Lys Arg Val His
115 120 125
His Arg His Ser Asn Ser Met Asp Gly Ser Thr Thr Ala Ser Phe Asp
130 135 140
Val Glu Ser Leu Met Ala Val Asp Gly Val Lys Lys Thr Met Ala Pro
145 150 155 160
Asp Arg Leu Ala Glu Leu Ala Leu Ile Asp Pro Lys Arg Ala Lys Arg
165 170 175
Ile Leu Ala Asn Arg Gln Ser Ala Ala Arg Ser Lys Glu Arg Lys Ile
180 185 190
Arg Tyr Thr Asn Glu Leu Glu Lys Lys Val Gln Thr Leu Gln Thr Glu
195 200 205
Ala Thr Asn Leu Ser Ala Gln Val Thr Met Leu Gln Arg Asp Thr Thr
210 215 220
Gly Leu Thr Thr Glu Asn Lys Glu Leu Lys Leu Arg Leu Gln Ala Met
225 230 235 240
Glu Gln Gln Ala Gln Leu Arg Asp Ala Leu Asn Glu Lys Leu Lys Glu
245 250 255
Glu Val Gln Arg Leu Arg Ile Gln Ala Gly Gln Val Ser Ala Met Asn
260 265 270
Gly Asn Pro Phe Asn Arg Gly Leu Ser Pro Gln Tyr Leu Thr His Gln
275 280 285
Pro Ala Pro His His Phe Gly Val Leu Gln Thr Pro His Gln Gln Gln
290 295 300
Gln Gln Gln Gln Gln Leu Gln Met Pro His Ser Ser Thr Asn Asn Pro
305 310 315 320
Thr Leu Asn Gly Gln Pro Gln Pro His Phe Met Asp Phe Asn Gln Arg
325 330 335
Ala
<210> 2
<211> 1014
<212> DNA
<213> GbVIP1核苷酸序列(GbVIP1)
<400> 2
atggagcaaa agctgcgaat ggagatagac cagatgccac cacgtggagc tcaccatagg 60
cgggctcatt ccgacacaac tttccgtttc gatgatcttc tcctcttcga cccctcggac 120
ctcgatcttt cctgccttga ccttccggat tcctcttcca atcccagtct gccacctgtc 180
gcacccgtac ctgctgaatc ctccgatgac tcctcatgca acggccctcc tcgctccacc 240
ctcaataacc ctaggcatat ccgtagcctt tctgttgact ctgatttctt tgatggactc 300
gggttgactg gacccgcgat ctccggagga gctggggatg agaaatttgg cgggaaaaga 360
ggtgcaggag agaagagggt tcaccataga catagtaact cgatggatgg ttcgactacg 420
gcatcgtttg acgttgagtc cttgatggcc gttgatggtg ttaagaaaac tatggctcct 480
gatagacttg ctgagcttgc ccttatcgat cccaagagag ctaaaaggat tctggctaac 540
aggcaatcag ctgcgcgttc aaaggagagg aagattcgat acacgaatga actagagaag 600
aaggttcaga ctcttcagac agaagctacc aatctctccg cacaagtcac aatgttacag 660
agagacacta ctgggttgac tactgagaac aaggaactga aactacggct acaggctatg 720
gagcaacaag cgcagcttag ggatgctttg aatgaaaaat tgaaggaaga agtgcaacgg 780
cttaggatac aagctggtca agtgtctgct atgaatggaa atcctttcaa tagaggacta 840
tctcctcaat atttaaccca ccaacctgct ccacatcact ttggcgtcct gcagacaccg 900
catcaacaac aacagcagca gcagcagctg cagatgcctc attcatccac caataacccg 960
actttgaacg gacagcctca acctcacttt atggatttta accagagggc atag 1014
<210> 3
<211> 25
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 3
tacgccgccg cttcttccgc ctaca 25
<210> 4
<211> 25
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 4
cttaccaagc atttccttcc aacat 25
<210> 5
<211> 20
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 5
ccaatcccag tctgccacct 20
<210> 6
<211> 21
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 6
tcaacccgag tccatcaaag a 21
<210> 7
<211> 39
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 7
acgggggact ctagaggatc ctacgccgcc gcttcttcc 39
<210> 8
<211> 44
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 8
cgatcgggga aattcgagct ccttaccaag catttccttc caac 44
<210> 9
<211> 25
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 9
tacgccgccg cttcttccgc ctaca 25
<210> 10
<211> 25
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 10
cttaccaagc atttccttcc aacat 25
<210> 11
<211> 44
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 11
ggcctcgaga cgcgtgagct cgccgttgat ggtgttaaga aaac 44
<210> 12
<211> 46
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 12
agaaggcctc catggggatc catagcctgt agccgtagtt tcagtt 46
Claims (2)
1.抗黄萎病相关蛋白GbVIP1在棉花抗黄萎病中的应用,其中,蛋白GbVIP1的氨基酸序列如SEQ ID NO:1所示。
2.抗黄萎病相关蛋白GbVIP1在通过基因工程手段培育抗黄萎病陆地棉品种中的应用,其中,蛋白GbVIP1的氨基酸序列如SEQ ID NO:1所示。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811277409.2A CN109293758B (zh) | 2018-10-30 | 2018-10-30 | 抗黄萎病相关蛋白GbVIP1及其编码基因与应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811277409.2A CN109293758B (zh) | 2018-10-30 | 2018-10-30 | 抗黄萎病相关蛋白GbVIP1及其编码基因与应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109293758A CN109293758A (zh) | 2019-02-01 |
| CN109293758B true CN109293758B (zh) | 2021-06-08 |
Family
ID=65145375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811277409.2A Active CN109293758B (zh) | 2018-10-30 | 2018-10-30 | 抗黄萎病相关蛋白GbVIP1及其编码基因与应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109293758B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112851783B (zh) * | 2021-04-16 | 2021-08-31 | 中国农业科学院植物保护研究所 | 陆地棉GhCM2蛋白及其编码基因和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8053638B2 (en) * | 2006-08-07 | 2011-11-08 | The Samuel Roberts Noble Foundation | Method for agrobacterium-mediated transformation of plants |
| CN103266116A (zh) * | 2013-05-31 | 2013-08-28 | 江苏省农业科学院 | 棉花黄萎病抗病相关基因GaVdr1及其应用 |
| CN105753956A (zh) * | 2016-05-13 | 2016-07-13 | 中国农业科学院植物保护研究所 | 陆地棉GhB2蛋白及其编码基因与应用 |
| CN105899668A (zh) * | 2013-11-11 | 2016-08-24 | 巴斯夫欧洲公司 | 抗真菌青霉属菌株,其杀真菌extrolite,及其用途 |
| CN106047896A (zh) * | 2016-08-17 | 2016-10-26 | 上海交通大学 | 一种青蒿bZIP类转录因子编码序列及克隆方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110258735A1 (en) * | 2008-12-22 | 2011-10-20 | Marie Coffin | Genes and uses for plant enhancement |
-
2018
- 2018-10-30 CN CN201811277409.2A patent/CN109293758B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8053638B2 (en) * | 2006-08-07 | 2011-11-08 | The Samuel Roberts Noble Foundation | Method for agrobacterium-mediated transformation of plants |
| CN103266116A (zh) * | 2013-05-31 | 2013-08-28 | 江苏省农业科学院 | 棉花黄萎病抗病相关基因GaVdr1及其应用 |
| CN105899668A (zh) * | 2013-11-11 | 2016-08-24 | 巴斯夫欧洲公司 | 抗真菌青霉属菌株,其杀真菌extrolite,及其用途 |
| CN105753956A (zh) * | 2016-05-13 | 2016-07-13 | 中国农业科学院植物保护研究所 | 陆地棉GhB2蛋白及其编码基因与应用 |
| CN106047896A (zh) * | 2016-08-17 | 2016-10-26 | 上海交通大学 | 一种青蒿bZIP类转录因子编码序列及克隆方法与应用 |
Non-Patent Citations (4)
| Title |
|---|
| "PREDICTED: Gossypium hirsutum transcription factor VIP1-like (LOC107951626), mRNA",NCBI Reference Sequence: XM_016886734.1;genbank;《GenBank》;20160518;第1-2页 * |
| 2个棉花抗黄萎病相关基因的克隆及功能分析;张凯;《中国优秀硕士学位论文全文数据库 农业科技辑》;20190815(第08期);D046-91 * |
| Isolation and characterization of the GbVIP1 gene and response to Verticillium wilt in cotton and tobacco;ZHANG Kai et al.;《Journal of Cotton Research》;20190308;第2卷;第1-11页 * |
| The Plant VirE2 Interacting Protein 1.A Molecular Link between the Agrobacterium T-Complex and the Host Cell Chromatin?;Abraham Loyter et al.;《Plant Physiology》;20050731;第138卷;第1318-1321页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109293758A (zh) | 2019-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105949295B (zh) | 与植物开花时间相关的蛋白及其编码基因与应用 | |
| CN110283824B (zh) | 一种利用CsXTH04基因沉默以提高柑橘对溃疡病抗性的方法 | |
| CN102010466A (zh) | 植物抗性相关蛋白myb及其编码基因与应用 | |
| CN115873085B (zh) | 一种大豆基因GmMAX2a在植物抗逆中的应用 | |
| CN102719449A (zh) | 苹果抗逆相关基因MdSIMYB1的克隆及其应用 | |
| CN118531024A (zh) | 基因OsNeK2及其编码蛋白和调控水稻抗纹枯病应用 | |
| CN116925200A (zh) | 一种具有抗逆能力的蛋白质及其编码基因和应用 | |
| CN109971766B (zh) | 一种与植物耐逆相关蛋白PwRBP1及其编码基因与应用 | |
| CN101250220A (zh) | 一种植物抗逆相关蛋白及其编码基因与应用 | |
| CN103834653A (zh) | 水稻冷诱导启动子p-LTT1及其应用 | |
| CN109293758B (zh) | 抗黄萎病相关蛋白GbVIP1及其编码基因与应用 | |
| CN120060291A (zh) | 一种茉莉花vigs沉默体系及其构建方法和应用 | |
| CN113913457A (zh) | 一种抑制或杀灭桃蛀螟的方法及其应用 | |
| CN117286150B (zh) | 三七病程相关蛋白1基因PnPR1-3及其应用 | |
| CN112359049A (zh) | 一种岷江百合几丁质酶基因LrCHI2及其应用 | |
| CN114703199B (zh) | 一种植物抗旱性相关的基因TaCML46及应用 | |
| CN102660556A (zh) | 小麦生长素合成基因TaYUCCA1序列及其应用和植物表达载体 | |
| CN117737116A (zh) | 紫花苜蓿MsSAP26基因及用途 | |
| CN110607309A (zh) | 一种可增强植物抗旱作用的蛋白及其编码基因和应用 | |
| CN113564182B (zh) | 蝴蝶花SVP-like基因的应用及获得蝴蝶花基因沉默或敲除植株的方法 | |
| CN110951752B (zh) | 一种大豆生物调控基因的应用 | |
| CN115927452A (zh) | 一种利用基因编辑改良大豆炸荚的方法 | |
| CN114591984A (zh) | OsAP79基因诱导水稻抗褐飞虱的应用 | |
| CN118667831B (zh) | 一种抗旱基因CrWRKY40、扩增方法及在植物抗旱改良中的应用 | |
| CN105732785B (zh) | 蛋白质GhDHN1在调控植物抗逆性中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |
